After attracting record sums in 2021, startup founders faced extinction-level threats two years later as interest rates rose and the dollars dried up. Where did 2025 end up on this fundraising ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...